Please see below for a list of search results.
Today the Human Tissue Authority (HTA) has announced licence fee levels for the 2018/19 business year. The new licence fees come into effect from April 2018 and will be calculated on the same basis as 2017/18.
You can read the full sector breakdowns here.
DIs and LHs both play key roles in the licensing arrangements under the Human Tissue Act (2004) and the Q&S Regulations. This section explains the roles and responsibilities of these individuals under the Q&S Regulations. Separate guidance is available on the role of Designated...
The Regulations (PDF) were implemented on 5 July 2007 bringing the into UK law. The directive and it's subsequent updates are as follows:
Procurement is defined as the processes by which tissues and cells are made available, including the physical act of removing tissue and the donor selection and evaluation.
For information about temporary body storage in the event of a pandemic outbreak resulting in mass fatalities please go to guidance on temporary body storage arrangements in a pandemic situation
Designated Individuals have a key role to play in implementing the requirements of the Human Tissue Act. They are the person under whose supervision the licensed activity is authorised to be carried out. They have the primary (legal) responsibility under Section 18 of...
In certain circumstances, the Human Tissue Act 2004 makes provision for a Licence Holder or Designated Individual or Licence Applicant to make Representations against a proposed licensing decision and / or make an Appeal to the HTA about a licensing decision.
Do I need a licence under the Human Tissue (Quality and Safety for Human Application) Regulations 2007?
The HTA licenses a number of activities relating to human tissue. We are also responsible for carrying out inspections to ensure licence conditions are being met. These activities are laid out in the Human Tissue Act and associated Regulations.
The activities licensed by the HTA are: